4.8 Article

Mesoporous silica nanorods intrinsically doped with photosensitizers as a multifunctional drug carrier for combination therapy of cancer

Journal

NANO RESEARCH
Volume 8, Issue 3, Pages 751-764

Publisher

TSINGHUA UNIV PRESS
DOI: 10.1007/s12274-014-0558-0

Keywords

mesoporous silica nanorods; chlorin e6; photodynamic therapy; drug delivery; combination therapy

Funding

  1. National Basic Research Programs of China (973 Program) [2012CB932600, 2011CB911002]
  2. National Natural Science Foundation of China [51222203, 51132006]
  3. Jiangsu Key Laboratory for Carbon-Based Functional Materials and Devices
  4. Jiangsu Natural Science Fund for Distinguished Young Scholars
  5. Priority Academic Program Development (PAPD) of Jiangsu Higher Education Institutions

Ask authors/readers for more resources

Mesoporous silica nanoparticles (MSNs) have attracted tremendous attention in recent years as drug delivery carriers due to their large surface areas, tunable sizes, facile modification and considerable biocompatibility. In this work, we fabricate an interesting type of MSNs which are intrinsically doped with photosensitizing molecules, chlorin e6 (Ce6). By increasing the amount of Ce6 doped inside the silica matrix, it is found that the morphology of MSNs changes from spheres to rod-like shapes. The obtained Ce6-doped mesoporous silica nanorods (CMSNRs) are not only able to produce singlet oxygen for photodynamic therapy, but can also serve as a drug delivery platform with high drug loading capacity by utilizing their mesoporous structure. Compared to spherical nanoparticles, it is found that CMSNRs with a larger aspect ratio show much faster uptake by cancer cells. With doxorubicin (DOX) employed as a model drug, the combined photodynamic and chemotherapy is carried out, achieving synergistic anti-tumor effects both in vitro and in vivo. Our study presents a new design of an MSN-based drug delivery platform, which intrinsically is fluorescent and able to serve as a photodynamic agent, promising for future imaging-guided combination therapy of cancer.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available